66.15 F
New York, US
June 18, 2025
PreetNama
English News

Covid-19 death toll drops to 5 in New York, once the US epicenter

Five people died Saturday from the coronavirus in New York state, the lowest daily death toll the state has reported since March 15.

Saturday’s total compared to 13 fatalities the day before as the number of fatalities caused by the virus continues to plummet in the state. During the peak of the pandemic in April, nearly 800 people were dying a day from coronavirus.

Click here for full US-19 coverage

“We are on the exact opposite end,” Gov. Andrew Cuomo said in an interview with NBC’s “Meet the Press.”

New York still leads the nation in Covid-19 deaths with nearly 25,000, according to the state’s official tally, which doesn’t include people who likely died of the disease.

Meanwhile, fewer than 900 patients were hospitalized Saturday for Covid-19, down from a peak of over 18,000 in April.

The governor cautioned that the numbers could spike again if New Yorkers let down their guard down and fail to follow social distancing and mask-wearing requirements.

“I’m now afraid of the spread coming from other states because we are one country and people travel,” Cuomo said. “I’m afraid the infection rate in the other states will come back to New York and raise that rate again.”

Confirmed daily infections in the US hit an all-time high of 40,000 on Friday, prompting officials in Texas and Florida to reverse course and close down bars in their states again.

US Health and Human Services Secretary Alex Azar stressed that “the window is closing” for the US to take action to effectively curb the coronavirus.

Related posts

he plans for AstraZeneca’s new headquarters and large R&D campus in Cambridge were unveiled in 2013, but its costs and timeframe have exceeded the initial estimate of 330 million pounds and an aimed completion date of 2016. AstraZeneca, which has a large portfolio of treatments for diseases such as cancer, heart disease and diabetes, said the centre would support research into specialised medicines and next-generation therapeutics, including gene-editing and cell therapies. “We will have advances that could come to the clinic in the next three, four years, that can lead to really effective new drugs in various aspects of treating cancer,” Dr Susan Galbraith, AstraZeneca’s executive vice president, Oncology Research & Development, told Reuters in an interview. “I’m very optimistic about the fact that we can make a big difference to this disease in the coming decade”.

On Punjab

‘Trump cheats at golf’: Mike Bloomberg mocks US Prez with billboard message

On Punjab

Allies prepare for abrupt US U-turn as Joe Biden shifts priorities

On Punjab